Business

Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics

SANTA CLARA, Calif., November 12, 2025--Agilent Technologies Inc. (NYSE: A) today announced that the University of California has received an Agilent Research Catalyst (ARC) award on behalf of Professor Marie Heffern at the UC Davis campus. The award recognizes Professor Heffern’s innovative research into the analytical characterization of peptide and protein therapeutics targeting incretin and related pathways, an emerging area critical to advancing treatments for diabetes and obesity.

articleAgilent Technologies, Inc.November 12, 20253/company/agilent-technologies-inc/news/agilent-research-catalyst-arc-award-presented-to-uc-davis-for-breakthroughs-in-peptide-therapeutics
Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics

About this update from Agilent Technologies, Inc.

[{"type":"image","alt":"Professor Marie Heffern alongside an Agilent 1260 Infinity II LC System (courtesy of UC Davis).","displaySize":"","headline":null,"caption":"Professor Marie Heffern alongside an Agilent 1260 Infinity II LC System (courtesy of UC Davis).","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":413,"url":"https://media.zenfs.com/en/business-wire.com/49f98a03a50c54188136d478e422b158"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sc5SkXlrZxBhC2CblONOpQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTgyNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/49f98a03a50c54188136d478e422b158","width":480,"height":413}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1000,"height":404,"url":"https://media.zenfs.com/en/business-wire.com/6d23f375731e6474ae9fcdb6d8f5c97b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3OoNrvJVWGnwbwyodVp1KQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM4ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6d23f375731e6474ae9fcdb6d8f5c97b","width":960,"height":388},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/y_c4EBCd5k64C9xe5Sdn7A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwMDA7aD04MDg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/6d23f375731e6474ae9fcdb6d8f5c97b","width":1000,"height":404}}},{"type":"text","content":"UC Davis researcher recognized for pioneering analytical approaches in peptide drug development","length":95,"tagName":"p"},{"type":"text","content":"SANTA CLARA, Calif., November 12, 2025--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the University of California has received an Agilent Research Catalyst (ARC) award on behalf of Professor Marie Heffern at the UC Davis campus. The award recognizes Professor Heffern’s innovative research into the analytical characterization of peptide and protein therapeutics targeting incretin and related pathways, an emerging area critical to advancing treatments for diabetes and obesity.","length":508,"tagName":"p"},{"type":"text","content":"Professor Heffern is a faculty member in the Department of Chemistry at UC Davis. Her research focuses on understanding how trace metal ions, such as copper, iron, and zinc, interact with incretin-based peptide therapeutics, incl...

More updates from Agilent Technologies, Inc.

UC DavisAgilentAgilent Research Catalystpeptide therapeuticstherapeutic developmentanalytical toolsdrug stabilityinteractionsARCpeptide mapping